MannKind Shares Jump 16 Percent After Finalizing Research Deal

Shares of MannKind Corp. jumped more than 16 percent Tuesday after the Westlake Village biotech finalized a previously announced agreement with United Therapeutics Corp. to develop an inhalable drug to treat a form of hypertension.

Eyenuk Expands Screening Service to Germany

Eyenuk Inc., a Woodland Hills company that uses artificial technology to screen for diabetic complications in the eyes, will expand its service to a diabetes treatment center in Germany.

Kaiser Permanente Reaches Tentative Agreement With Unions

Kaiser Permanente has reached a tentative labor agreement with an alliance of union health care workers in eight states and Washington, D.C. that includes more than 30,000 workers in Southern California.

Workers, City Settle With Canoga Park Home Care Provider

City Attorney Mike Feuer has reached a settlement with a San Fernando Valley home care provider that allegedly failed to pay its employees minimum wage and overtime.

Avita Medical Receives Australian Tax Rebate

Avita Medical Ltd. has received a $1 million tax rebate from the Australian government, the biotechnology company announced Tuesday

Avita Medical’s Burn Treatment Gets FDA Approval

The Food and Drug Administration has approved Avita Medical Ltd.’s Recell system for treating severe burns, the biotechnology company said Friday.

Amgen Partners with L.A. County on BioLA Project

Amgen Inc. has partnered with Los Angeles County to form a new organization aimed at advancing the region’s life sciences industry, the Thousand Oaks biotechnology company announced Thursday.

SnapMD Secures $7.1 Million Investment

SnapMD Inc., a telemedicine company based in Glendale, announced it has raised $7.1 million in funding.

Preview: Drug Deal Extends MannKind's Life Expectancy

BIOTECH: Timely infusion of $45 million bolsters finances.

Research Deal Gives Cash Infusion to MannKind

Shares of MannKind Corp. jumped nearly 90 percent Tuesday after the Westlake Village biotech announced an agreement with United Therapeutics Corp. to develop an inhalable drug to treat a form of hypertension.

Second Sight Selects Manufacturing-Savvy COO

Second Sight Medical Products Inc. has named Pat Ryan as its chief operating officer effective immediately.

Providence Hires Athletic Trainers for Valley Schools

Athletic trainers from Providence Health & Services will be placed in seven San Fernando Valley high schools, the hospital system announced Tuesday.

Lancaster Doctor Convicted for Medicare Kickback Conspiracy

A doctor in Lancaster has been convicted by a federal jury of participating in a Medicare fraud scheme.

Preview: Dog Drug Theory

On Aug. 6, Immix announced that its drug Imx-110 had successfully brought a dog named Jerry into remission from late-stage lymphoma.

Workers Strike at Providence Tarzana Medical Center

Hundreds of union-affiliated workers at Providence Tarzana Medical Center staged a one-day strike and a demonstration on Aug. 16 to protest what they described as unfair labor practices, including frequent shift cancellations and wages that lag behind the region’s rising cost of living.

Tease photo